Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo-Controlled, Outpatient Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo-Controlled, Outpatient Study

Published:1998-04 Issue:4 Volume:38 Page:281-287
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache

Author:

Teall Judith,Tuchman Michael,Cutler Neal,Gross Michael,Willoughby Ernest,Smith Betty,Jiang Kai,Reines Scott,Block Gilbert,

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1526-4610.1998.3804281.x/fullpdf

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Russian tableted rizatriptan 10 mg in the treatment of migraine attacks in clinical practice;Neurology, Neuropsychiatry, Psychosomatics;2024-08-20

2. The 5-HT1B and 5-HT1D agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans;Handbook of Clinical Neurology;2024

3. Evidence-based symptomatic treatment of migraine;Handbook of Clinical Neurology;2024

4. Gepants in the acute management of migraine;Pain Management;2023-11

5. Comparison between metamizole and triptans for migraine treatment: a systematic review and network meta-analysis;Headache Medicine;2022-01-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP